248 related articles for article (PubMed ID: 22923402)
1. Evidence of in vivo prophage induction during Clostridium difficile infection.
Meessen-Pinard M; Sekulovic O; Fortier LC
Appl Environ Microbiol; 2012 Nov; 78(21):7662-70. PubMed ID: 22923402
[TBL] [Abstract][Full Text] [Related]
2. Prophage carriage and diversity within clinically relevant strains of Clostridium difficile.
Shan J; Patel KV; Hickenbotham PT; Nale JY; Hargreaves KR; Clokie MR
Appl Environ Microbiol; 2012 Sep; 78(17):6027-34. PubMed ID: 22706062
[TBL] [Abstract][Full Text] [Related]
3. Prophage-stimulated toxin production in Clostridium difficile NAP1/027 lysogens.
Sekulovic O; Meessen-Pinard M; Fortier LC
J Bacteriol; 2011 Jun; 193(11):2726-34. PubMed ID: 21441508
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Functional Prophages in Clostridium difficile.
Sekulović O; Fortier LC
Methods Mol Biol; 2016; 1476():143-65. PubMed ID: 27507339
[TBL] [Abstract][Full Text] [Related]
5. Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut model.
Saxton K; Baines SD; Freeman J; O'Connor R; Wilcox MH
Antimicrob Agents Chemother; 2009 Feb; 53(2):412-20. PubMed ID: 18710908
[TBL] [Abstract][Full Text] [Related]
6. Characterization of temperate phages infecting Clostridium difficile isolates of human and animal origins.
Sekulovic O; Garneau JR; Néron A; Fortier LC
Appl Environ Microbiol; 2014 Apr; 80(8):2555-63. PubMed ID: 24532062
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile.
Pawlowski SW; Archbald-Pannone L; Carman RJ; Alcantara-Warren C; Lyerly D; Genheimer CW; Gerding DN; Guerrant RL
J Hosp Infect; 2009 Oct; 73(2):185-7. PubMed ID: 19709778
[No Abstract] [Full Text] [Related]
8. Effects of subinhibitory concentrations of antibiotics on colonization factor expression by moxifloxacin-susceptible and moxifloxacin-resistant Clostridium difficile strains.
Denève C; Bouttier S; Dupuy B; Barbut F; Collignon A; Janoir C
Antimicrob Agents Chemother; 2009 Dec; 53(12):5155-62. PubMed ID: 19805572
[TBL] [Abstract][Full Text] [Related]
9. Prophage Carriage and Genetic Diversity within Environmental Isolates of
Blau K; Gallert C
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203173
[No Abstract] [Full Text] [Related]
10. High Prevalence and Genetic Diversity of Large phiCD211 (phiCDIF1296T)-Like Prophages in Clostridioides difficile.
Garneau JR; Sekulovic O; Dupuy B; Soutourina O; Monot M; Fortier LC
Appl Environ Microbiol; 2018 Feb; 84(3):. PubMed ID: 29150513
[No Abstract] [Full Text] [Related]
11. Phage ϕC2 mediates transduction of Tn6215, encoding erythromycin resistance, between Clostridium difficile strains.
Goh S; Hussain H; Chang BJ; Emmett W; Riley TV; Mullany P
mBio; 2013 Nov; 4(6):e00840-13. PubMed ID: 24255122
[TBL] [Abstract][Full Text] [Related]
12. Diverse temperate bacteriophage carriage in Clostridium difficile 027 strains.
Nale JY; Shan J; Hickenbotham PT; Fawley WN; Wilcox MH; Clokie MR
PLoS One; 2012; 7(5):e37263. PubMed ID: 22624004
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in vitro.
Spigaglia P; Barbanti F; Louie T; Barbut F; Mastrantonio P
Antimicrob Agents Chemother; 2009 Jun; 53(6):2463-8. PubMed ID: 19364867
[TBL] [Abstract][Full Text] [Related]
14. As Clear as Mud? Determining the Diversity and Prevalence of Prophages in the Draft Genomes of Estuarine Isolates of Clostridium difficile.
Hargreaves KR; Otieno JR; Thanki A; Blades MJ; Millard AD; Browne HP; Lawley TD; Clokie MR
Genome Biol Evol; 2015 May; 7(7):1842-55. PubMed ID: 26019165
[TBL] [Abstract][Full Text] [Related]
15. Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008.
Ilchmann C; Zaiss NH; Speicher A; Christner M; Ackermann G; Rohde H
Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1571-3. PubMed ID: 20632051
[TBL] [Abstract][Full Text] [Related]
16. The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, China.
Cheng JW; Liu C; Kudinha T; Xiao M; Fan X; Yang CX; Wei M; Liang GW; Shao DH; Xiong ZJ; Hou X; Yu SY; Wang Y; Yang QW; Su JR; Xu YC
Int J Antimicrob Agents; 2020 Jul; 56(1):105981. PubMed ID: 32330584
[TBL] [Abstract][Full Text] [Related]
17. Determination of the attP and attB sites of phage CD27 from Clostridium difficile NCTC 12727.
Williams R; Meader E; Mayer M; Narbad A; Roberts AP; Mullany P
J Med Microbiol; 2013 Sep; 62(Pt 9):1439-1443. PubMed ID: 23699063
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones.
Phillips ST; Nagaro K; Sambol SP; Johnson S; Gerding DN
Anaerobe; 2011 Aug; 17(4):166-9. PubMed ID: 21511046
[TBL] [Abstract][Full Text] [Related]
19. Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections.
Kim J; Pai H; Seo MR; Kang JO
BMC Infect Dis; 2012 May; 12():109. PubMed ID: 22571633
[TBL] [Abstract][Full Text] [Related]
20. Identification and Initial Characterization of Prophages in Vibrio campbellii.
Lorenz N; Reiger M; Toro-Nahuelpan M; Brachmann A; Poettinger L; Plener L; Lassak J; Jung K
PLoS One; 2016; 11(5):e0156010. PubMed ID: 27214518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
